Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Facing a "slow-motion disaster"--the UN meeting on noncommunicable diseases.

Rosenbaum L, Lamas D.

N Engl J Med. 2011 Dec 22;365(25):2345-8. doi: 10.1056/NEJMp1112235. Epub 2011 Nov 16. No abstract available.

PMID:
22087629
2.

Systems medicine and integrated care to combat chronic noncommunicable diseases.

Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J, Agusti A, Brightling C, Cambon-Thomsen A, Cesario A, Abdelhak S, Antonarakis SE, Avignon A, Ballabio A, Baraldi E, Baranov A, Bieber T, Bockaert J, Brahmachari S, Brambilla C, Bringer J, Dauzat M, Ernberg I, Fabbri L, Froguel P, Galas D, Gojobori T, Hunter P, Jorgensen C, Kauffmann F, Kourilsky P, Kowalski ML, Lancet D, Pen CL, Mallet J, Mayosi B, Mercier J, Metspalu A, Nadeau JH, Ninot G, Noble D, Oztürk M, Palkonen S, Préfaut C, Rabe K, Renard E, Roberts RG, Samolinski B, Schünemann HJ, Simon HU, Soares MB, Superti-Furga G, Tegner J, Verjovski-Almeida S, Wellstead P, Wolkenhauer O, Wouters E, Balling R, Brookes AJ, Charron D, Pison C, Chen Z, Hood L, Auffray C.

Genome Med. 2011 Jul 6;3(7):43. doi: 10.1186/gm259.

3.

Current controversies and future perspectives in chronic obstructive pulmonary disease.

Agustí A, Vestbo J.

Am J Respir Crit Care Med. 2011 Sep 1;184(5):507-13. doi: 10.1164/rccm.201103-0405PP. Review.

PMID:
21680951
4.

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.

Garcia-Aymerich J, Gómez FP, Benet M, Farrero E, Basagaña X, Gayete À, Paré C, Freixa X, Ferrer J, Ferrer A, Roca J, Gáldiz JB, Sauleda J, Monsó E, Gea J, Barberà JA, Agustí À, Antó JM; PAC-COPD Study Group.

Thorax. 2011 May;66(5):430-7. doi: 10.1136/thx.2010.154484. Epub 2010 Dec 21.

PMID:
21177668
5.

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine.

Agusti A, Sobradillo P, Celli B.

Am J Respir Crit Care Med. 2011 May 1;183(9):1129-37. doi: 10.1164/rccm.201009-1414PP. Epub 2010 Dec 17. Review.

PMID:
21169466
6.

Network medicine: a network-based approach to human disease.

Barabási AL, Gulbahce N, Loscalzo J.

Nat Rev Genet. 2011 Jan;12(1):56-68. doi: 10.1038/nrg2918. Review.

7.

C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach.

Dahl M, Vestbo J, Zacho J, Lange P, Tybjærg-Hansen A, Nordestgaard BG.

Thorax. 2011 Mar;66(3):197-204. doi: 10.1136/thx.2009.131193. Epub 2010 Nov 8.

PMID:
21059738
8.

Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.

N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883.

9.

Characterisation of COPD heterogeneity in the ECLIPSE cohort.

Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators.

Respir Res. 2010 Sep 10;11:122. doi: 10.1186/1465-9921-11-122.

10.

An integrative systems biology approach to understanding pulmonary diseases.

Auffray C, Adcock IM, Chung KF, Djukanovic R, Pison C, Sterk PJ.

Chest. 2010 Jun;137(6):1410-6. doi: 10.1378/chest.09-1850.

PMID:
20525651
11.

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ.

Am J Respir Crit Care Med. 2010 Sep 1;182(5):598-604. doi: 10.1164/rccm.200912-1843CC. Epub 2010 Jun 3.

PMID:
20522794
12.

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J; EPI-SCAN Steering Committee.

Respir Res. 2010 May 25;11:63. doi: 10.1186/1465-9921-11-63.

13.

Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome.

Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR.

Am J Respir Crit Care Med. 2010 Aug 1;182(3):325-31. doi: 10.1164/rccm.200912-1869OC. Epub 2010 Apr 8.

PMID:
20378728
14.

New paradigms in the pathogenesis of chronic obstructive pulmonary disease II.

Sethi S, Mallia P, Johnston SL.

Proc Am Thorac Soc. 2009 Sep 15;6(6):532-4. doi: 10.1513/pats.200905-025DS. Review.

PMID:
19741263
15.

Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study.

Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damås JK, Aukrust P, Bakke PS.

Eur Respir J. 2010 Mar;35(3):540-8. doi: 10.1183/09031936.00088209. Epub 2009 Jul 30.

16.

The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.

Kolsum U, Roy K, Starkey C, Borrill Z, Truman N, Vestbo J, Singh D.

Int J Chron Obstruct Pulmon Dis. 2009;4:149-56. Epub 2009 Apr 15.

17.

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?

Man SF, Xing L, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Zhang X, Vessey R, Walker TG, Celli BR, Sin DD.

Eur Respir J. 2008 Dec;32(6):1451-7. doi: 10.1183/09031936.00153207. Epub 2008 Sep 17.

18.

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

Patel BD, Coxson HO, Pillai SG, Agustí AG, Calverley PM, Donner CF, Make BJ, Müller NL, Rennard SI, Vestbo J, Wouters EF, Hiorns MP, Nakano Y, Camp PG, Nasute Fauerbach PV, Screaton NJ, Campbell EJ, Anderson WH, Paré PD, Levy RD, Lake SL, Silverman EK, Lomas DA; International COPD Genetics Network.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):500-5. doi: 10.1164/rccm.200801-059OC. Epub 2008 Jun 19.

PMID:
18565956
19.

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.

Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Gan WQ, Rousseau R; ABC (Advair, Biomarkers in COPD) Investigators.

Am J Respir Crit Care Med. 2008 Jun 1;177(11):1207-14. doi: 10.1164/rccm.200709-1356OC. Epub 2008 Feb 28.

PMID:
18310480
20.

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE).

Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R; ECLIPSE investigators.

Eur Respir J. 2008 Apr;31(4):869-73. doi: 10.1183/09031936.00111707. Epub 2008 Jan 23.

Supplemental Content

Support Center